Insights

Immunotherapy Focus Dragonfly Therapeutics focuses on developing therapies that leverage multispecific antibody technology to activate the immune system, presenting opportunities in the growing field of immunotherapy.

Strategic Collaborations Through collaborations with leading pharmaceutical companies like Merck, AbbVie, Gilead, and Bristol Myers Squibb, Dragonfly is expanding its network and potentially opening doors for new partnerships and collaborations.

Robust Pipeline With a deep pipeline of preclinical candidates and clinical assets, Dragonfly has a range of opportunities for sales engagement, including licensing deals, joint ventures, and strategic alliances.

Competitive Landscape In comparison to similar companies like Arvinas, Exelixis, and Xencor, Dragonfly's focus on immune system-targeted therapies provides a competitive edge that can be leveraged in sales pitches and market positioning.

Financial Growth Potential With revenue in the range of $10M - 50M, Dragonfly Therapeutics presents sales opportunities for investors, partners, and customers looking to be part of a biopharmaceutical company with growth potential and innovative therapeutic approaches.

Similar companies to Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics, Inc. Tech Stack

Dragonfly Therapeutics, Inc. uses 8 technology products and services including SAP, NetSuite, Microsoft Excel, and more. Explore Dragonfly Therapeutics, Inc.'s tech stack below.

SAP
Customer Relationship Management
NetSuite
E-commerce
Microsoft Excel
Editors
Google Font API
Font Scripts
ADP Workforce Now
Human Capital Management
CTT
Logistics
Microsoft
Miscellaneous
New Relic
Real User Monitoring

Media & News

Dragonfly Therapeutics, Inc.'s Email Address Formats

Dragonfly Therapeutics, Inc. uses at least 1 format(s):

Dragonfly Therapeutics, Inc. Email Formats	Example	Percentage
First.Last@dragonflytx.com	John.Doe@dragonflytx.com	79%
First@dragonflytx.com	John@dragonflytx.com	19%
FirstMiddle.Last@dragonflytx.com	JohnMichael.Doe@dragonflytx.com	1%
Fir.Last@dragonflytx.com	Joh.Doe@dragonflytx.com	1%

Frequently Asked Questions

Where is Dragonfly Therapeutics, Inc.'s headquarters located?

Dragonfly Therapeutics, Inc.'s main headquarters is located at Waltham, MA 02451 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is Dragonfly Therapeutics, Inc.'s phone number?

You can contact Dragonfly Therapeutics, Inc.'s main corporate office by phone at

+1-617-588-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dragonfly Therapeutics, Inc.'s official website and social media links?

Dragonfly Therapeutics, Inc.'s official website is dragonflytx.com and has social profiles on LinkedIn.

How much revenue does Dragonfly Therapeutics, Inc. generate?

As of November 2024, Dragonfly Therapeutics, Inc.'s annual revenue reached $35M.

What is Dragonfly Therapeutics, Inc.'s SIC code NAICS code?

Dragonfly Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dragonfly Therapeutics, Inc. have currently?

As of November 2024, Dragonfly Therapeutics, Inc. has approximately 123 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Executive Officer: B. H.Chief Financial Officer: S. A.Chief Scientific Officer And Head Of Research And Development: A. C.. Explore Dragonfly Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Dragonfly Therapeutics, Inc. belong to?

Dragonfly Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Dragonfly Therapeutics, Inc. use?

Dragonfly Therapeutics, Inc.'s tech stack includes SAPNetSuiteMicrosoft ExcelGoogle Font APIADP Workforce NowCTTMicrosoftNew Relic.

What is Dragonfly Therapeutics, Inc.'s email format?

Dragonfly Therapeutics, Inc.'s email format typically follows the pattern of . Find more Dragonfly Therapeutics, Inc. email formats with LeadIQ.

When was Dragonfly Therapeutics, Inc. founded?

Dragonfly Therapeutics, Inc. was founded in 2016.

Dragonfly Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.

Company Overview

Headquarters: Waltham, MA 02451 US
Phone number: +1-617-588-****
Website: dragonflytx.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200